öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºËïê»Åô
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º218

ËùÊôԺУ£ºÖйúÒ©¿Æ´óѧ
ËùÊôԺϵ£ºÒ©Ñ§Ôº
Ö°³Æ£º¸±½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÒ©Îﻯѧ
Ñо¿ÁìÓò£º Ö÷ÒªÑо¿·½ÏòΪҩÎﻯѧ¡¢»¯Ñ§ÉúÎïѧ¼°Ò©ÎïÉè¼Æѧ
Ñо¿ÁìÓò£º Ö÷ÒªÑо¿·½ÏòΪҩÎﻯѧ¡¢»¯Ñ§ÉúÎïѧ¼°Ò©ÎïÉè¼Æѧ [ÊÕÆð]




ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºsunhaopeng@163.com


¸öÈ˼òÊö :
Ëïê»Åô£¬ÄУ¬ÖйúÒ©¿Æ´óѧҩѧԺҩÎﻯѧϵ£¬¸±½ÌÊÚ¡£2006Äê±ÏÒµÓÚÖйúÒ©¿Æ´óѧ»ù´¡Ò©Ñ§Àí¿Æ»ùµØ°àöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬»ñÀíѧѧʿѧλ¡£Í¬ÄêÃâÊÔÍƼöΪÖйúÒ©¿Æ´óѧҩÎﻯѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØ˶²©Á¬¶ÁÑо¿Éú¡£2011Äê»ñÀíѧ²©Ê¿Ñ§Î»£¬Í¬ÄêÁôУÈνÌ£¬2014Äê½úÉýΪ¸±½ÌÊÚ¡£

¿ÆÑй¤×÷ :
×÷Ϊ¿ÎÌ⸺ÔðÈËÖ÷³ÖÁ˹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿Ò»ÏÇàÄê»ù½ðÏîÄ¿Ò»Ï×÷ΪÖ÷Òª²ÎÓëÈ˲μÓÁ˹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîÄ¿¶àÏî¡£ÒÑ·¢±íSCIÊÕ¼ÂÛÎÄ70ƪ¡£
½üÆÚÂÛÎļ°Öø×÷£º1.Li, Q. Yang, H. Y. Chen, Y. Sun, H. P. *Recent Progress in the Identification of Selective Butyrylcholinesterase Inhibitors for Alzheimer's Disease. Eur. J. Med. Chem.2017, 132, 294-309.2.Chen, Y. Lin, H. Z. Zhu, J. Gu, K. Li, Q. He, S. Y. Lu, X. Tan, R. X. Pei, Y. Q. Wu, L. Bian, Y. Y. * Sun, H. P. *Design, synthesis, in vitro and in vivo evaluation of tacrine-cinnamic acid hybrids as multi-target acetyl- and butyrylcholinesterase inhibitors against Alzheimer's disease. RSC Adv.2017, 7, 33851-33867.3.Sun, H. P. 1,* Zhu, J.1 Lin, H. Z. Gu, K. Feng, F. * Recent progress in the development of small molecule Nrf2 modulators: a patent review (2012-2016). Expert Opin. Ther. Pat.2017, 27, 763-785.4.Chen, Y. Lin, H. Z. Yang, H. Y. Tan, R. X. Bian, Y. Y. Fu, T. M. Li, W. Wu, L. Pei, Y. Q. * Sun, H. P. *Discovery of New Acetyl- and Butyrylcholinesterase Inhibitors through Structure-Based Virtual Screening. RSC Adv.2017, 7, 3429-3438.